Lerøy Seafood Group ASA: Continuous progress in biological performance

PROGRESS IN BIOLOGICAL PERFORMANCE CONTINUES

Lerøy Seafood Group ASA today reports consolidated operating EBIT of NOK 906 million for the second quarter of 2024.

CEO Henning Beltestad comments: “The positive trend in biological performance has continued in the second quarter and we are performing well in a quarter characterized by declining salmon prices. The number of lice treatments has been significantly reduced and growth and survival rates have increased substantially compared to the average of the past five years.